Literature DB >> 31416501

[Pure red cell aplasia in children: a clinical analysis of 16 cases].

Zhong-Jian Wang1, Yi-Ning Qiu, Hui Yu, Ling-Fang Tan, Ping Qu, Run-Ming Jin.   

Abstract

OBJECTIVE: To study the clinical features, treatment, and prognosis of pure red cell aplasia (PRCA) in children.
METHODS: A retrospective analysis was performed for the clinical data of 16 children with PRCA. The outcome and prognosis of patients treated with prednisone combined with Huaiqihuang granules versus prednisone alone were evaluated.
RESULTS: All the 16 children complained of symptoms of anemia including pale or sallow complexion. Of 12 children undergoing pathogen test, 7 (58%) were found to have pathogen infection, among which human cytomegalovirus was the most common. Lymphocyte subsets were measured for 7 children, among whom 5 (71%) had lymphocyte immune disorder. Six children were found to have abnormalities in immunoglobulin and complement. The 8 children treated with prednisone combined with Huaiqihuang granules had a median follow-up time of 21.5 months, among whom 1 was almost cured, 1 was relieved, and 6 were obviously improved; the median onset time of treatment was 1 month, and 2 children had disease recurrence in the course of drug reduction or withdrawal. The 8 children in the prednisone alone treatment group had a median follow-up time of 34 months, among whom 4 were almost cured, and 4 were obviously improved; the median onset time of treatment was 2.5 months, and 4 children had recurrence during drug reduction or withdrawal.
CONCLUSIONS: Children with PRCA usually complain of anemia-related symptoms. Laboratory tests show pathogen infection in some children with PRCA, and most of children have immune disorders. Glucocorticoids have a good therapeutic effect, but some children relapse in the course of drug reduction or withdrawal. Combined treatment with prednisone and Huaiqihuang granules may have a faster onset of action and less possibility of recurrence.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31416501      PMCID: PMC7389893     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  6 in total

1.  Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.

Authors:  Franca Fagioli; Paola Quarello; Marco Zecca; Edoardo Lanino; Paola Corti; Claudio Favre; Mimmo Ripaldi; Ugo Ramenghi; Franco Locatelli; Arcangelo Prete
Journal:  Br J Haematol       Date:  2014-02-24       Impact factor: 6.998

2.  [Effects of huai qi huang on cytokines Th1, Th2 and Th17 and phagocytosis of alveolar macrophages in rats with asthma].

Authors:  Hong-Mei Li; Qing-Nan He; Xiao-Yan Li; Lan-Jun Shuai; Pin Zhou; Zhu-Wen Yi
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2011-09

Review 3.  Diamond Blackfan anemia: a model for the translational approach to understanding human disease.

Authors:  Adrianna Vlachos; Lionel Blanc; Jeffrey M Lipton
Journal:  Expert Rev Hematol       Date:  2014-03-26       Impact factor: 2.929

4.  [Clinical analysis of 32 patients with acquired pure red cell aplasia].

Authors:  J F Chen; J M Kang; Y F Zhang; M F Wang; C X Dong; L Y Wang; L P Guo; L H Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-11-14

5.  [Chinese expert consensus on the treatment and diagnosis of acquired pure red cell aplasia (2015)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2015-05

6.  Rational management approach to pure red cell aplasia.

Authors:  Suresh Kumar Balasubramanian; Meena Sadaps; Swapna Thota; Mai Aly; Bartlomiej P Przychodzen; Cassandra M Hirsch; Valeria Visconte; Tomas Radivoyevitch; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.